DIN 02199270 — NITOMAN 25 MG
NITOMAN is a tablet of Tetrabenazine marketed by BAUSCH HEALTH, CANADA INC.. The full Tetrabenazine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02199270
- Brand name
- NITOMAN
- Active ingredient
- Tetrabenazine
- Strength
- 25 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- BAUSCH HEALTH, CANADA INC.
- Health Canada status
- MARKETED
- Drug class
- Monoamine-depleting agent (VMAT2 inhibitor)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Tetrabenazine products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02407590 | APO-TETRABENAZINE | 25 MG | TABLET | APOTEX INC | MARKETED |
| 02402424 | PMS-TETRABENAZINE | 25 MG | TABLET | PHARMASCIENCE INC | MARKETED |
| 02410338 | TETRABENAZINE TABLETS | 25 MG | TABLET | STERIMAX INC | DORMANT |